Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys
Authors
Keywords
-
Journal
BRAIN
Volume 134, Issue 7, Pages 2057-2073
Publisher
Oxford University Press (OUP)
Online
2011-06-26
DOI
10.1093/brain/awr137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glutamate Receptors as Therapeutic Targets for Parkinsons Disease
- (2012) Kari Johnson et al. CNS & Neurological Disorders-Drug Targets
- Subthalamic neuronal firing in obsessive-compulsive disorder and Parkinson disease
- (2010) Brigitte Piallat et al. ANNALS OF NEUROLOGY
- Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
- (2010) Colleen M. Niswender et al. Annual Review of Pharmacology and Toxicology
- Gene–Environment Interactions in Parkinson's Disease: The Importance of Animal Modeling
- (2010) M P Horowitz et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade
- (2010) Mark R. Stefani et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- 18F-FECNT: Validation as PET dopamine transporter ligand in parkinsonism
- (2010) Gunasingh Masilamoni et al. EXPERIMENTAL NEUROLOGY
- Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions
- (2010) Janelle Drouin-Ouellet et al. GLIA
- Reduction of L-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
- (2010) T. H. Johnston et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity
- (2010) A. L. Rodriguez et al. MOLECULAR PHARMACOLOGY
- A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys
- (2010) Daniella Rylander et al. NEUROBIOLOGY OF DISEASE
- Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys
- (2010) Nicolas Morin et al. NEUROPHARMACOLOGY
- Activation of metabotropic glutamate receptor 5 improves recovery after spinal cord injury in rodents
- (2009) Kimberly R. Byrnes et al. ANNALS OF NEUROLOGY
- Mitochondrial dysfunction in Parkinson's disease
- (2009) Konstanze F. Winklhofer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Neurotransmission in Parkinson’s disease: beyond dopamine
- (2009) P. Barone EUROPEAN JOURNAL OF NEUROLOGY
- Glutamate, excitotoxicity, and programmed cell death in parkinson disease
- (2009) W. Michael Caudle et al. EXPERIMENTAL NEUROLOGY
- Mitochondrial dynamics in Parkinson's disease
- (2009) Victor S. Van Laar et al. EXPERIMENTAL NEUROLOGY
- A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
- (2009) E Berry-Kravis et al. JOURNAL OF MEDICAL GENETICS
- Pharmacological Modulation of Glutamate Transmission in a Rat Model of L-DOPA-Induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear Signaling
- (2009) D. Rylander et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Can we achieve neuroprotection with currently available anti-parkinsonian interventions?
- (2009) C. W. Olanow NEUROLOGY
- The locus ceruleus norepinephrine system: Functional organization and potential clinical significance
- (2009) E. E. Benarroch NEUROLOGY
- Calcium homeostasis, selective vulnerability and Parkinson's disease
- (2009) C. Savio Chan et al. TRENDS IN NEUROSCIENCES
- The promiscuous mGlu5 receptor – a range of partners for therapeutic possibilities?
- (2009) Michael K. Bird et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Targets for neuroprotection in Parkinson's disease
- (2008) Talene A. Yacoubian et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Imaging neurodegeneration in Parkinson's disease
- (2008) Nicola Pavese et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Functional Neuroanatomy of the Noradrenergic Locus Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part II: Physiological and Pharmacological Manipulations and Pathological Alterations of Locus Coeruleus Activity in Humans
- (2008) E. Samuels et al. Current Neuropharmacology
- Progress in neuroprotection in Parkinson’s disease
- (2008) A. H. V. Schapira EUROPEAN JOURNAL OF NEUROLOGY
- Neuronal activity in the subthalamic nucleus modulates the release of dopamine in the monkey striatum
- (2008) Yasushi Shimo et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Quantitative Analysis of Norepinephrine Transporter in the Human Brain Using PET with (S,S)-18F-FMeNER-D2
- (2008) R. Arakawa et al. JOURNAL OF NUCLEAR MEDICINE
- The neuropathological basis for depression in Parkinson's disease
- (2008) Pasquale G. Frisina et al. PARKINSONISM & RELATED DISORDERS
- Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease
- (2007) Giovanna Levandis et al. NEUROBIOLOGY OF DISEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started